Biomedical Association of Students for Excellence (BASE)

07/06/2026

The side effects no one reported: How Reddit and AI are changing drug safety

AI scanning Reddit uncovered surprising side effects tied to blockbuster weight-loss drugs — including menstrual changes, chills, and unexplained fatigue.

03/06/2026

Order in the Deep: What a South Dakota Gold Mine Reveals About Earth’s Hidden Biosphere. One of the enduring assumptions about life in the deep terrestrial subsurface is that it is sparse, slow and, to a degree, ecologically simple. The logic is understandable. Below the reach of sunlight, under high pressure and often with very limited access to energy-rich nutrients, one might expect microbial life to persist only in a marginal and rather uniform state. However....

Microorganisms buried deep underground

27/05/2026

The ChAdOx1 BDBV vaccine is based on the chimpanzee adenovirus Oxford (ChAdOx) viral vector platform. This technology enables the delivery of viral antigens—in this case, proteins from Bundibugyo ebolavirus—into host cells, eliciting both humoral and cellular immune responses

A new vaccine has been designed specifically to target the Bundibugyo species of Ebolavirus.

25/05/2026

Clinical trial recruitment is often discussed in terms of awareness, eligibility criteria, and patient motivation. Far less attention is paid to a more basic prerequisite: whether a motivated patient can reach a study team at all. For many prospective participants, reaching out to a trial by email is the first step toward enrollment, yet those emails frequently receive no response.

To better understand how often this happens, AllClinicalTrials.com conducted a structured outreach experiment examining researcher responsiveness across publicly listed trials. The results point to a systemic friction point that is rarely quantified but has direct consequences for enrollment efficiency and patient trust https://www.pharmamicroresources.com/2026/05/the-silent-inbox-in-clinical-trials.html

Clinical trial best practices

21/05/2026

"Beyond Hostility: Pakistan, India, and the Strategic Logic of an Emerging World Order", explores the strategic transformation unfolding across South Asia amid shifting global power dynamics. The article argues that the emerging multipolar order, changing U.S.-China equations, and the rise of geo-economics are slowly altering the traditional logic of perpetual Pakistan-India confrontation.

- It examines how Science Diplomacy, Climate Diplomacy, regional connectivity, and economic pragmatism may gradually create new incentives for managed coexistence despite deep-rooted mistrust and strategic competition.

- As the world moves toward a new era of technological competition, strategic realignments, and geopolitical war-gaming, South Asia may be approaching a decisive historical moment.

11/05/2026

The new antimicrobial is a sulphur-rich polymer material which overcome previous limitations in sulphur-based preparations and shows impressive potency against a variety of fungal and bacterial pathogens

Staph bacteria. Image: Centers for Disease Control and Prevention's Public Health Image Library (PHIL), with identification number #11157. CC 3.0.Antimicrobial resistance continues to be global burden in human health and food production. Microbial resistance to antibiotics and/or antimicrobial agent...

10/05/2026

Everything you need to know about hantavirus: While most hantaviruses infect humans through animal-to-human transmission, the Andes strain is capable of spreading between people, highlighting global vulnerabilities in interconnected travel networks. This strain is associated with hantavirus pulmonary syndrome, which can lead to microvascular leakage and acute respiratory distress syndrome:

Andes hantavirus: The mortality rate is significantly higher than COVID-19. In parts of southern Chile, mortality among hospitalized patients can approach 60%.

08/05/2026

Swashing, swarming, gliding – new mechanisms as to how bacteria move in liquids have been discovered. In this article, I take a look at some fascinating new findings: https://www.linkedin.com/pulse/swashing-swarming-gliding-new-insights-how-bacteria-professor-tim-lgrme/

04/05/2026

Encyclopedic Dictionary of Pharmaceutical Microbiology. I've put together an introductory text, in encyclopedia form, available as a paperback or e-book. Available from Amazon.

Pharmaceutical microbiology sits at the intersection of science, regulation, engineering, and risk management — yet the language of the discipline is often fragmented, inconsistent, or poorly defined. The Encyclopedic Dictionary of Pharmaceutical Microbiology was written to solve that problem.

This authoritative reference brings together over 1,390 clearly written, inspection‑ready definitions, covering the full scope of modern pharmaceutical microbiology — from core microbiological concepts to cleanroom design, contamination control strategies, sterilization, disinfection, environmental monitoring, water systems, data integrity, and regulatory expectations.

Unlike a conventional glossary, this book provides concise yet contextual explanations, allowing readers not only to understand what a term means, but why it matters in practice. Many entries go beyond simple definitions, offering regulatory context, practical interpretation, and links to real‑world application in GMP environments.

Key features

Over 1,390 alphabetically arranged definitions from A to Z

Covers sterile and non‑sterile manufacturing, cleanrooms, EM, utilities, CCS, and sterility assurance

Integrates EU GMP Annex 1, ISO, pharmacopeial, and QA concepts into everyday terminology

Written in clear, professional language suitable for industry, academia, and regulators

Ideal as both a desk reference and a training companion

Pharmaceutical microbiology sits at the intersection of science, regulation, engineering, and risk management — yet the language of the discipline is often fragmented, inconsistent, or poorly defined. The was written to solve that problem. This authoritative reference brings together , cove...

27/04/2026

What Happens When Innovation Outpaces Talent Development in Microbiology? The life sciences skills gap continues to widen as breakthroughs in microbiology accelerate at an unprecedented pace. Advances in synthetic biology and antimicrobial resistance research influence what is possible in research and commercialization. However, while innovation surges forward, talent pipelines struggle to keep pace.

This lag leaves organizations searching for professionals who can bridge deep scientific expertise with technical and operational demands. The growing disconnect places pressure on research and development timelines and on large-scale production readiness. It also signals a critical need for more agile workforce strategies that can grow alongside scientific progress:

Working life in a microbiology lab